 It 's designed to teach the immune system to recognise compounds found in prostate cancer cells and is being given to men who have already been treated for the cancer .
The vaccine is made from pieces of a protein called TARP that 's found in about 95 per cent of prostate cancers .
Prostate cancer is the most common cancer in men in the UK .